ABRAMS MICHAEL S
Insider CIK 1497702 · BNLB.OB CHIEF FINANCIAL OFFICER, Director · ARTH Chief Financial Officer · NRXP Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2025-02-07 | 2025-02-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2023-08-31 | 2023-09-08 | 20,584 | — | $0 | 20,584 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | P Buy | 2023-08-31 | 2023-09-08 | 10,292 | $0.28 | $2.9K | 10,292 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2022-11-10 | 2022-11-10 | 900,000 | — | $0 | 900,000 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2022-07-06 | 2022-07-08 | 36,000 | — | $0 | 724,346 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2022-07-06 | 2022-07-08 | 724,346 | — | $0 | 0 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award | 2022-07-06 | 2022-07-08 | 108,652 | — | $0 | 108,652 | SEC↗ |
| ARTH Arch Therapeutics, Inc. | A Award deriv | 2021-09-27 | 2021-10-01 | 350,000 | — | $0 | 350,000 | SEC↗ |
| FTLF FITLIFE BRANDS, INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FTLF FITLIFE BRANDS, INC. | P Buy | 2014-06-11 | 2014-06-12 | 1,000 | $2.15 | $2.1K | 403,000 | SEC↗ |
| BNLB.OB BOND LABORATORIES, INC. | A Award deriv | 2013-01-16 | 2013-01-28 | 500,000 | $0.10 | $50.0K | 500,000 | SEC↗ |
| BNLB.OB BOND LABORATORIES, INC. | A Award | 2013-01-03 | 2013-01-28 | 2,675,000 | — | $0 | 3,420,000 | SEC↗ |
| BNLB.OB BOND LABORATORIES, INC. | P Buy | 2012-12-28 | 2013-01-03 | 1,050,565 | — | $0 | 1,795,565 | SEC↗ |
| BNLB.OB BOND LABORATORIES, INC. | J Other | 2012-08-08 | 2012-10-18 | 120,000 | $0.05 | $6.0K | 745,000 | SEC↗ |
| BNLB.OB BOND LABORATORIES, INC. | A Award deriv | 2012-05-09 | 2012-05-10 | 100,000 | $0.09 | $9.0K | 100,000 | SEC↗ |